MDT

94.99

-0.35%↓

VEEV

292.58

+1.89%↑

A

140.97

+1.06%↑

HQY

90.94

-1.4%↓

TLRY

1.54

-8.33%↓

MDT

94.99

-0.35%↓

VEEV

292.58

+1.89%↑

A

140.97

+1.06%↑

HQY

90.94

-1.4%↓

TLRY

1.54

-8.33%↓

MDT

94.99

-0.35%↓

VEEV

292.58

+1.89%↑

A

140.97

+1.06%↑

HQY

90.94

-1.4%↓

TLRY

1.54

-8.33%↓

MDT

94.99

-0.35%↓

VEEV

292.58

+1.89%↑

A

140.97

+1.06%↑

HQY

90.94

-1.4%↓

TLRY

1.54

-8.33%↓

MDT

94.99

-0.35%↓

VEEV

292.58

+1.89%↑

A

140.97

+1.06%↑

HQY

90.94

-1.4%↓

TLRY

1.54

-8.33%↓

Search

Quidel Corp

Slēgts

28.48 4.94

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

27.14

Max

28.99

Galvenie mērījumi

By Trading Economics

Darbinieki

6,600

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt

Prognoze 12 mēnešiem

+44.64% upside

Dividendes

By Dow Jones

Nākamie ieņēmumi

2025. g. 6. nov.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

127M

1.5B

Iepriekšējā atvēršanas cena

23.54

Iepriekšējā slēgšanas cena

28.48

Quidel Corp Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 16. okt. 21:10 UTC

Galvenie tirgus virzītāji

Kezar Life Sciences Shares Surge After Break with FDA, Restructuring Plan

2025. g. 16. okt. 19:03 UTC

Iegādes, apvienošanās, pārņemšana

Canada Signals Limited Concern Over U.S. Government Stakes in Canadian Miners -- 2nd Update

2025. g. 16. okt. 17:58 UTC

Iegādes, apvienošanās, pārņemšana

Canada Signals Limited Concern Over U.S. Government Stakes in Canadian Miners -- Update

2025. g. 16. okt. 17:12 UTC

Peļņas

Ray-Ban Maker EssilorLuxottica's Revenue Surges to Quarterly Record -- Update

2025. g. 16. okt. 17:12 UTC

Iegādes, apvienošanās, pārņemšana

Canada Signals Limited Concern Over US Government Stakes in Canadian Miners

2025. g. 16. okt. 16:59 UTC

Iegādes, apvienošanās, pārņemšana

Airbus's Takeover of Spirit AeroSystems Plants Gets French Antitrust Clearance

2025. g. 16. okt. 23:44 UTC

Tirgus saruna

Gold Climbs Amid Safe-Haven Demand -- Market Talk

2025. g. 16. okt. 23:42 UTC

Tirgus saruna

Nikkei May Fall, Tracking Wall Street's Declines -- Market Talk

2025. g. 16. okt. 23:42 UTC

Tirgus saruna

Global Equities Roundup: Market Talk

2025. g. 16. okt. 22:15 UTC

Peļņas

China Tower: Results Supported by Higher Contributions From Energy, Smart Tower Business >0788.HK

2025. g. 16. okt. 22:15 UTC

Peļņas

China Tower 9-Mos Rev CNY74.32B Vs. CNY72.45B >0788.HK

2025. g. 16. okt. 22:15 UTC

Peļņas

China Tower 9-Mos Net CNY8.71B Vs. Net CNY8.15B >0788.HK

2025. g. 16. okt. 22:02 UTC

Tirgus saruna

Global Equities Roundup: Market Talk

2025. g. 16. okt. 22:02 UTC

Tirgus saruna

Santos Drifts Into 'Oversold Territory' -- Market Talk

2025. g. 16. okt. 20:50 UTC

Tirgus saruna

Financial Services Roundup: Market Talk

2025. g. 16. okt. 20:50 UTC

Tirgus saruna
Peļņas

Health Care Roundup: Market Talk

2025. g. 16. okt. 20:23 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2025. g. 16. okt. 20:23 UTC

Tirgus saruna

Recession Risks to Push Canada Toward October Rate Cut -- Market Talk

2025. g. 16. okt. 20:20 UTC

Peļņas

These Stocks Moved the Most Today: TSMC, Salesforce, HPE, F5, United Airlines, Travelers, J.B. Hunt, Praxis Precision, and More -- Barrons.com

2025. g. 16. okt. 20:08 UTC

Iegādes, apvienošanās, pārņemšana

Jack in the Box to Sell Del Taco With Big Markdown. The Stock Plunged. -- Barrons.com

2025. g. 16. okt. 19:37 UTC

Iegādes, apvienošanās, pārņemšana

Crypto Industry Dives Deeper Into Prediction Markets as Kraken Buys Exchange -- Barrons.com

2025. g. 16. okt. 19:26 UTC

Peļņas

Oracle Weighs In on Cloud Margins. The Stock Is Rising. -- Barrons.com

2025. g. 16. okt. 19:24 UTC

Tirgus saruna

U.S. Natural Gas Falls on Mild Weather, Ample Storage -- Market Talk

2025. g. 16. okt. 19:23 UTC

Tirgus saruna

Oil Falls As Oversupply Concerns Outweigh India News -- Market Talk

2025. g. 16. okt. 19:23 UTC

Peļņas

Oracle Weighs In on Cloud Margins. The Stock Is Rising. -- Barrons.com

2025. g. 16. okt. 18:35 UTC

Tirgus saruna
Peļņas

Charles Schwab Logs Another Quarter of Record Revenues, Earnings -- Market Talk

2025. g. 16. okt. 18:31 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2025. g. 16. okt. 18:31 UTC

Tirgus saruna

Global Equities Roundup: Market Talk

2025. g. 16. okt. 18:31 UTC

Tirgus saruna

Charles Schwab Readies Spot Crypto Trading -- Market Talk

2025. g. 16. okt. 16:57 UTC

Tirgus saruna

Oil Futures Lose Ground as EIA Reports Crude Stock Build -- Market Talk

Salīdzinājums

Cenas izmaiņa

Quidel Corp Prognoze

Cenas mērķis

By TipRanks

44.64% augšup

Prognoze 12 mēnešiem

Vidējais 39.5 USD  44.64%

Augstākais 62 USD

Zemākais 26 USD

Pamatojoties uz 8 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Quidel Corp — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt

8 ratings

4

Pirkt

3

Turēt

1

Pārdot

Finanšu rādītāji

$

Par Quidel Corp

QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point-of-Care business unit provides instruments and tests to provide rapid results across a continuum of point-of-care settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; amplification systems; and sample-to-result molecular instruments and tests for syndromic infectious disease diagnostics. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, and internationally. The company was incorporated in 1979 and is headquartered in San Diego, California.
help-icon Live chat